Franklin Resources
PALI icon

Franklin Resources’s Palisade Bio PALI Stock Holding History

Franklin Resources’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Buy
5,785,189
+692,627
+14% +$1.26M ﹤0.01% 1234
2025
Q4 		$12M Buy
+5,092,562
New +$9.79M ﹤0.01% 1110

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Franklin Resources's PALI Position: Q1 2026 in Review

Franklin Resources increased its Palisade Bio (PALI) stake by 14% in Q1 2026, buying an estimated $1.26M and bringing the position to 5,785,189 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

Franklin Resources first reported a position in PALI in Q4 2025 and has held it in 2 quarters since. The position peaked at $12M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Franklin Resources held 5,785,189 shares of Palisade Bio worth $10.1M as of Q1 2026.
  • Franklin Resources bought 692,627 Palisade Bio shares in Q1 2026, an estimated $1.26M.
  • Palisade Bio made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1234 holding.
  • Franklin Resources first reported a position in Palisade Bio in Q4 2025 and has held it in 2 quarters since.
  • Franklin Resources's Palisade Bio position peaked at $12M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.